The briefing
Yale researchers reported that terazosin reduced the scarring response in fibroblasts from patients with pulmonary fibrosis. The findings point to a possible therapeutic avenue that warrants further study.
Original headline
Terazosin suppressed scarring in pulmonary fibrosis fibroblasts